Identification of myxobacteria-derived HIV inhibitors by a high-throughput two-step infectivity assay.
about
Antibiotics from myxobacteria.Antiviral drug discovery: broad-spectrum drugs from nature.Antiviral activity and specific modes of action of bacterial prodigiosin against Bombyx mori nucleopolyhedrovirus in vitro.Actinobacteria and Myxobacteria-Two of the Most Important Bacterial Resources for Novel Antibiotics.Modification of the Host Cell Lipid Metabolism Induced by Hypolipidemic Drugs Targeting the Acetyl Coenzyme A Carboxylase Impairs West Nile Virus Replication.Identification of a dibenzocyclooctadiene lignan as a HIV-1 non-nucleoside reverse transcriptase inhibitor.Natural products from myxobacteria: novel metabolites and bioactivities.The myxobacterial metabolite ratjadone A inhibits HIV infection by blocking the Rev/CRM1-mediated nuclear export pathway.The Myxobacterial Metabolite Soraphen A Inhibits HIV-1 by Reducing Virus Production and Altering Virion Composition.A resveratrol analog termed 3,3',4,4',5,5'-hexahydroxy-trans-stilbene is a potent HIV-1 inhibitor.Total Synthesis of Leupyrrins A1 and B1 , Highly Potent Antifungal Agents from the Myxobacterium Sorangium cellulosum.Antibiotics from Gram-negative bacteria: a comprehensive overview and selected biosynthetic highlights.Targeting de novo lipogenesis as a novel approach in anti-cancer therapy.Benzyl-2-Acetamido-2-Deoxy-α-d-Galactopyranoside Increases Human Immunodeficiency Virus Replication and Viral Outgrowth Efficacy In Vitro.
P2860
Q38212867-7DCFC9D7-245C-4349-BEAD-F18750242864Q38260235-B474E808-C98B-4220-8D93-4EC179CC2491Q38810468-97C3CAD5-7B2A-4A12-9BF9-7A7E5301A6C3Q38814785-0CD8B256-AD2F-4246-B83A-C59B72C792C8Q38824741-ABDC531C-3671-46C8-BB11-FAF897E5764DQ38856111-E40D6AD5-6FB5-4FCD-9F62-8F88BA4B41FBQ39025967-3A4C2897-71A2-44A9-9025-0F2E3FE1BC90Q39029310-5A265495-9E3E-4511-A1DA-C35723928F46Q40190121-9785A0C5-EE63-4BB3-BD3B-D07BAD4AE6B8Q41728933-8DF9FD0E-D4E1-4982-8FC1-9EDB9F36F755Q48185649-20709711-7B75-4F74-AD0B-6B27BDC09500Q48223572-3AA61E5E-15F9-4EC3-A119-E7425C269030Q48608544-2D694EC0-2C4D-492F-AA12-E0171C5DFCCDQ50334467-22BE3AE6-84F6-4C68-80F5-9D8758D7AED9
P2860
Identification of myxobacteria-derived HIV inhibitors by a high-throughput two-step infectivity assay.
description
2013 nî lūn-bûn
@nan
2013 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Identification of myxobacteria ...... ut two-step infectivity assay.
@ast
Identification of myxobacteria ...... ut two-step infectivity assay.
@en
Identification of myxobacteria ...... ut two-step infectivity assay.
@nl
type
label
Identification of myxobacteria ...... ut two-step infectivity assay.
@ast
Identification of myxobacteria ...... ut two-step infectivity assay.
@en
Identification of myxobacteria ...... ut two-step infectivity assay.
@nl
prefLabel
Identification of myxobacteria ...... ut two-step infectivity assay.
@ast
Identification of myxobacteria ...... ut two-step infectivity assay.
@en
Identification of myxobacteria ...... ut two-step infectivity assay.
@nl
P2093
P2860
P356
P1476
Identification of myxobacteria ...... ut two-step infectivity assay.
@en
P2093
Bettina Hinkelmann
Eric Fleta-Soriano
Florenz Sasse
Heinrich Steinmetz
Juana Diez
Rolf Jansen
Ronald Frank
P2860
P2888
P356
10.1186/1475-2859-12-85
P577
2013-09-24T00:00:00Z
P5875
P6179
1031075754